Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 2 / Episode 13: Dr. Andy Tao {Purdue University}
Transcript
- 0:00Cancer cells are sneaky, ever changing, disruptive and hard to
- 0:04find. That does not deter scientists
- 0:07from searching. An award-winning Purdue
- 0:09researcher and his team have made an incredible discovery.
- 0:14Their findings may help create an earlier detection and
- 0:18treatment. Here's Martha Kaley, founder and
- 0:20executive. Director of earlier.
- 0:22Dot org with this week's edition of Isn't that interesting?
- 0:26All right, folks, this is an outstanding fellow who I told
- 0:32him it looks like with all of his work, he should be about 150
- 0:36years old, but he's not, as you can see.
- 0:39And so this is Doctor Andy Tao, and he is at Purdue.
- 0:43And I'll just give you a little bit of understanding what his
- 0:46experience is. He's a professor of biochemistry
- 0:49and founder and chief scientific officer at Timerol Analytical
- 0:55Operations. His research centers on mass.
- 1:00How? How can I say that?
- 1:01Spectrometry. Mass spectrometry.
- 1:03Yeah, I got it. Based proteomics and chemical
- 1:07biology with a focus of identifying low abundance
- 1:11proteins and post translational modifications relevant to cancer
- 1:16extracellular vesicles and biomarker discovery.
- 1:21I have he won the NSF which is National Science Foundation
- 1:27career award and I read about that award, Doctor Tao and it is
- 1:31just a remarkable award to to attain it at this point in your
- 1:37career. So absolute congratulations to
- 1:40that. Thank you.
- 1:41Thank you, Martha. So Doctor Tao submitted this
- 1:45grant proposal to our Medical Advisory Board in 2023 and we
- 1:51have such a brilliant medical Advisory Board that they would
- 1:56see this and decide that this would be something that we would
- 1:59fund. And the title of it is early
- 2:03detection of breast cancer through monitoring signature
- 2:06phosphoproteins from plasma derived extracellular vesicles.
- 2:12Now in studying this as well as studying the other research that
- 2:17I have studied this, this whole concept of extracellular
- 2:21vesicles was new information to me.
- 2:25And I think what has been learned is really dramatic, what
- 2:30all has been identified since this discovery.
- 2:34So can you tell me about that first?
- 2:37Yes, first that extra vesicles that we constantly maybe in the
- 2:43interviewer talk EVs, but hopefully audience not confused
- 2:48with electric vehicles. Yeah, so this one was
- 2:53discovering this actual vesicles maybe 30 or 35 years ago.
- 2:59So originally they thought it was called a platelet dust.
- 3:03So they found essentially in the blood, I called it basically
- 3:08garbage or something like that. And then slowly some biology
- 3:12involved, they found that. That's very interesting as now
- 3:16they found almost every type of cell or release these actual
- 3:20vesicles into essentially in the bloodstream end up in urine, in
- 3:25saliva in any kind by fluids that you can find find out.
- 3:29So so my lab started to work on this one is in my field can
- 3:34consider way too early. And my lab is also as my
- 3:39formation that my expertise in mass spectrometry.
- 3:43Mass spectrometry is a incredible powerful tool mainly
- 3:46to to analyse proteins. So we really focus on look at a
- 3:51protein so that of course protein is the major in terms of
- 3:55function wise major play for for a lot of these diseases or
- 3:59others. So that certainly makes sense
- 4:02for for my lab. And so from the these today's, I
- 4:06would say the on the research wise, these extra vesicles, the
- 4:11EV's when is potentially as diagnosis because you can't
- 4:16really get from bi fluids from less invisible blood sample and
- 4:21then complete non invisible from the saliva from urine, from even
- 4:26sweat. You can you can get them.
- 4:28So that's convenient especially for some of the other cancer
- 4:32such as in the brain or something that you can really no
- 4:35way to get to the samples unless people do surgery.
- 4:40And so if we be able to using extra vesicles from the Bible is
- 4:45like a CSF or plasma. Certainly it's tremendous
- 4:48convenient to monitor with that. And it is the extra vesicles
- 4:52also now become quite a big in, in, in 3rd therapeutics.
- 4:58So you can package the drug into it.
- 5:01And because it's nature coming from sale, there'll be much
- 5:04easier to deliver into these sales for therapeutics.
- 5:08So there's bigger effort using EVs for therapeutics.
- 5:11So maybe there's two sides. My lab is mainly involved with
- 5:15the first study for diagnosis. That's wonderful.
- 5:18Now when you're talking about the diagnosis and and following,
- 5:22I guess you would be able to monitor whether the therapeutics
- 5:26are working or not. I mean, the whole process of
- 5:30the, the phosphoproteins and the signature, which is the one that
- 5:36is astounding to me. The, the whole understanding of
- 5:40the dynamics and the work of those, the proteins and the
- 5:45study of that is just like really it's, it's a giant leap
- 5:51for, for, I think for our science looking at this.
- 5:54And I'm hoping that this would be of long run.
- 5:57It would be a valuable tool for assessing the presence of breast
- 6:02cancer far earlier. Is that correct?
- 6:06Yes, definitely. So if you allow me, so maybe for
- 6:10some of your audience, I explained a little bit about
- 6:12it's phosphoproteins. So say, say cancer certainly is
- 6:16very complicated and perform the end to end point of view.
- 6:20So today's majority cancer we consider is mutation driven,
- 6:24right. So there's certain mutations for
- 6:26breast cancer certainly break one and two certainly is one of
- 6:30the major mutations being discovered.
- 6:33So, but a lot of other mutations.
- 6:34So that's one end another end how the eventually become cancer
- 6:39tumor is a force for proteins. So, so in the middle, of course,
- 6:43there's a lot of things happening, right?
- 6:45So, so DNA repair all these mutations, all these all happen.
- 6:50Is it to end to end is the mutation and these mutation
- 6:54eventually lead to a lot of protein have the mutations.
- 6:58So their function is different. And so one of the particular 1
- 7:03is that once there's a mutation leaded to this frustration
- 7:07active on the enzymes called the kindness.
- 7:10And these kindness started to phosphate the randomly,
- 7:14unexpectedly on the proteins and these usually leading to the
- 7:18cell growth faster. And that is tumor.
- 7:21So of course, in the middle, very complicated or different
- 7:23factors or they could correct by themselves, but that's the
- 7:28growth of the cells all due to the phosphorylation.
- 7:32And because of these, these enzyme called a kindness.
- 7:36That's why so many for the inhibitors, inhibitors enzyme
- 7:39called a kindness so, so that's the phosphor proteins.
- 7:43So these really phosphor proteins reflection of cell
- 7:47growth. And so by identifying these
- 7:50signature phosphoprotein, certainly you can see the
- 7:52potential onset of progression of the cancer.
- 7:56So that's why it's exciting to to to observe these
- 8:00phosphoprotein with extra vesicles.
- 8:03The on the top of that to say we using bifruits usually these
- 8:08phosphorus cannot be seen. What happened is that in our
- 8:11blood, let's say our liver release a lot of another enzyme
- 8:16called phosphatase. So that's the reverse of the
- 8:20kindness essentially remove this phosphoprotein.
- 8:23So, so even these phosphoproteins are released
- 8:26into the blood, they immediately get chopped off.
- 8:29These phosphor group on the proteins and you don't usually
- 8:32don't detect them. So you if you, you, you get to
- 8:35these protein try to analyze the bladder, you don't see them.
- 8:38Yeah, that's was the situation. But it is extra vesicles, which
- 8:43is more like a small size cells. They have membrane everything.
- 8:47So they protect these phosphatase in the blood from
- 8:52basically hydrolyze degraded these these fossil proteins.
- 8:57So they maintain the signature original if these extra vesicle
- 9:01released by cancer cells, they remain there.
- 9:03That's was the the essential science behind why these extra
- 9:07vesica, the signature protein, can be used for diagnosis.
- 9:12So is the operative on this about how it mutates, is that
- 9:19genetic? What should I say?
- 9:21Is it genetic or is it just kind of happenstance or what?
- 9:26What might precipitate the? Mutation.
- 9:29So these typical I would say mainly to catheter when's
- 9:32genetic. Another is we always have the
- 9:34mutations and then the cell always can correct them and
- 9:38especially when we were young and then when you're getting
- 9:42older accumulation mutations. And then also our body
- 9:47self-defense system is getting weaker and weaker.
- 9:49We cannot correct them and we cannot care sales with
- 9:53mutations. So all these factor Commission.
- 9:56That's why people getting older tend to be getting much easier
- 10:00to detect. When you're the young, you don't
- 10:01see them often and the also the accumulation of the mutation and
- 10:06also difficult to to basic self corrections.
- 10:09So these are two factors. So essentially 2 mutations,
- 10:13genetically somatic they're called, typically accumulated
- 10:16these mutations over the years by environmentus or these
- 10:20factors. We all know we expose the
- 10:23sunshine, the potential beauty could cause mutations.
- 10:27So all could happen, yeah. Right.
- 10:29OK. So what do you see the, the when
- 10:33do you see that this can go into effect?
- 10:36And what do you see the long term view of vision?
- 10:40What's your vision of this? Yeah.
- 10:42So this is a certainly overall trend today and today's modern
- 10:46diagnosis and therapeutics. I would say the the overall how
- 10:51we and you try to take off our body including the disease cure
- 10:55the disease that one is how we be able to more accurate or
- 11:00convenient diagnosis early diagnosis as a your foundation
- 11:04for sure that called earlier. So, so the survival rate for
- 11:08breast cancer and for most every type of cancer, if you can
- 11:12detect earlier, you have a much better chances to, to cure them,
- 11:16right. And I think the breast cancer,
- 11:18the five year survival rate over 95% or more if you can detect
- 11:23early. So that's critical.
- 11:26Unfortunately, sometimes the such a thing is that people
- 11:29didn't realize unless you'd be in diagnosis.
- 11:32So, so early detection, yes, we, we think this is critical, but I
- 11:38think with this country's overall medical system,
- 11:41insurance system and sometimes the diagnosis is not pinpoint
- 11:46and they said, oh, you make may get a cancer, but 90% and all
- 11:51you get may already have cancer. But sometimes they may may not
- 11:55take that point out of which cancer is for example, this this
- 11:59there are ways to call the pan potentially look at multiple
- 12:04cancers in your body, but they cannot point to exact which
- 12:07cancer after that they need progress needed to scan every
- 12:11organ to find out. So insurance company didn't like
- 12:14that. So they they don't want to pay
- 12:17the money then you don't take exactly no.
- 12:19So all these preventers from going forget a more early
- 12:23screening or something like that, which is unfortunate.
- 12:26So science is there, we can do more early early screening.
- 12:30So in that case, how we can solve this problem?
- 12:32So #1 So we try to find a more convenient way, a cheaper way to
- 12:37the insurance company and willing to pay for it.
- 12:40So, so for now, put these EV based diagnosis based on blood
- 12:44or these and then I think if more people are willing to to do
- 12:48the screening and the insurance company in the future look at
- 12:51the cost versus the the, the overall consider much better in
- 12:56terms of the address, I think to tie them potentially will
- 13:00change. So that's certainly we work on
- 13:04it to try to be make it non invasive and also cheaper so
- 13:08that the earlier screening become much better.
- 13:13And the second of course is more accurate measurement and that's
- 13:17my lab is working on it to try to find these signature for
- 13:21supporting will be precisely reflected the breast cancer for
- 13:25example, identify them. Of course, research always
- 13:29started at limited cases and then we need to expand the
- 13:34larger populations in order to eliminate these false positives.
- 13:38So I think these kind of diagnosis is a special bladder
- 13:42based diagnosis always challenged by the limitation of
- 13:47false positive because a lot of these molecules due to these
- 13:51immune response you detected. And then of course when body
- 13:55getting wrong there a lot of immune responses very similar.
- 13:58So you end up look at a similar protein.
- 14:01So these are kind of challenge facing scientific research.
- 14:06So are these the EVs? Are they more prevalent in the
- 14:11blood as opposed to saliva or urine?
- 14:15Are they you would use a a blood test, right?
- 14:18Is that correct? Yes, yes.
- 14:20So actually my lab is doing multiple buy fruits, but
- 14:25sometimes we have to pick and choose which, which one we focus
- 14:29on. So I think the blood is more
- 14:32acceptable for, for, for I would say a lot of patients because
- 14:37they consider golden standard and you go to go to hospital
- 14:41unless you do the bladder cancer or other cancer, they consider
- 14:45urine is more more likely. And then a lot of diseases as
- 14:49they consider blood would be a better choice in terms of
- 14:53understanding. And so so although I would say
- 14:57in the future, probably because blood is still considered a
- 15:02little bit investment, especially if you have to
- 15:05collect the blood from the hospital or something like that.
- 15:08But a urine sample or saliva or something like that you can
- 15:11definitely do at home or these, right.
- 15:13So, so that's certainly picking choice.
- 15:17I think at this moment, I wouldn't say it's the reason we
- 15:20choose the bladder because there are so many bladder based
- 15:23diagnosis. We can compare against the
- 15:26golden standard to see that weather EV based diagnosis is a
- 15:30better choice. So that's why we use blood based
- 15:33diagnosis at this moment. And in terms of the EV wise and
- 15:39certainly bladder I would have say is the first because that
- 15:42after that today blood pass through different than the urine
- 15:46sample all these. So way that is all they connect
- 15:49in some degree bladder, they are a lot of EVs.
- 15:52So because of the bladder goes through different organs and
- 15:55different cells each cell now we know release EVs constantly.
- 16:01And so you end up a lot of EVs in the bladder for sure.
- 16:04So actual, but blood is the most complicated and also because
- 16:09bladder circulated in our body, so it's well regulated.
- 16:15And so that's why we we detect the bladder.
- 16:17If something goes wrong, you look at the bladder and because
- 16:20well regulated and then monitor the blood can see the way your
- 16:24body is correct or not. But but a urine sample or
- 16:27something that is because they're just quickly release
- 16:30out. So it's more dynamic and I would
- 16:33say for the accurate kind of disease or something that maybe
- 16:38urine is better, but at same time is very dynamic.
- 16:43You drink a coffee drink juice that affect the urine content.
- 16:47So that's make the diagnosis also more challenge in that
- 16:50sense, yeah. So how was, how did our grant
- 16:55assist you and in your work? And what's your next step?
- 16:59Yeah, Yeah. So that's actually not a very
- 17:02good question, especially today's environment.
- 17:05We all know that the new chamber government from last year, they
- 17:12include a lot of energy grants including National Cancer
- 17:17Institute and also the original proposal to cut almost like a
- 17:2240% or more research right and not although the Congress put it
- 17:27back. We don't know the the the fate.
- 17:30I believe they were passed so essentially flat funding
- 17:34originally we consider friend fund is not good, but not
- 17:37because the original proposed cut 40% and now come back
- 17:40flatter. Oh, it's good.
- 17:42So it's kind of ironic. So, so so that's what
- 17:46unfortunately, there's a situation and also on top of
- 17:48there's a there's one thing probably the other community
- 17:52don't know. But in the scientific field we
- 17:54know quite well is from last year Trump government, for some
- 17:58reason they switch the mechanism.
- 18:01So usually in nature funding, I mean a lot of cancers being by
- 18:05NCI, right, funding and wise. So mainly funded by using every
- 18:10year. So there's a well energy every
- 18:13year funding. We committed that much money
- 18:15next year with that much money. And then last year is the new
- 18:19government, they switched, they decided if I give you 5 year
- 18:23grant, I give you 5 year money immediately.
- 18:25So they don't want to commit next year to this grant there
- 18:28every year they want what happened is like started from
- 18:32last year. So what it means if they give
- 18:34him a five year grant or three-year grant, they
- 18:37immediately give three years and then you instead of finding 3
- 18:41new grants, they only can find in one grant, right?
- 18:44And then suddenly because that the the NCI funding rate,
- 18:49National Cancer Institute of funding rate from already very
- 18:53low, like 7 to 8 percentile drop immediately into 3 to 4
- 18:58percentile because of that. Yeah.
- 19:00So, so under that kind of funding and the environment is
- 19:04become almost like a larger peak to be honest, right.
- 19:08And so sometime we talk about it's so efficient, a lot of
- 19:13research, University of Professors Institute profess, we
- 19:17put in a lot of writings, but the chances are only three to
- 19:214%. I mean, from business point, a
- 19:23lot of us are very inefficient and you spend a lot of time to
- 19:27writing grants, but you only get a 30% of chance And so, so very
- 19:31frustrating. And your foundation certainly
- 19:33comes in as a alternative. Also sometime bridge fund for us
- 19:37to continue finding our research and then at the same time
- 19:42seeking next round of funding and from other fund of funding
- 19:46source as well. So that's what definitely is a
- 19:49great to my lab and we will be able to maintaining staff and
- 19:54graduate senior graduate students so that we don't lose
- 19:58lose the funding on ongoing project.
- 20:01Yeah, so that was precise. And also sometimes I would say
- 20:05NCI or these federal grant they tend to picking some so-called
- 20:11new science and. Some some science come up with
- 20:15new concept or something like that and and then ongoing
- 20:19research is supposed already made a progress.
- 20:21You just need maybe a few more years game reach.
- 20:24But by the time they say the times up, OK, and we are not
- 20:28going to find anymore. We move on to some new concept,
- 20:30new lease. So you, you have you, you, it's
- 20:33become difficult to to to get a finding and sometime you have to
- 20:37jump into different things. Is that so I would have said
- 20:40this is a special breast cancer certainly and you need to really
- 20:44propose. Oh, I have come relatively new
- 20:47ones, relatively new ones or something like that.
- 20:49So, so that's the foundation or something.
- 20:52And I certainly wouldn't look at that to consider the
- 20:55significance of this ongoing research on these.
- 20:58I think it was also incredible to support the research.
- 21:02Well, thank you. Well, I know one of the
- 21:04researchers I was speaking with said that she that what she
- 21:08really appreciated was that that the grant proposal was not
- 21:12difficult to submit. And I, that's one of the things
- 21:16that I don't want people wasting their time writing is.
- 21:21And that's why our medical advisory committee is so good
- 21:24because they can see the possibilities that and they know
- 21:29that that's what we're looking for.
- 21:31And that's also why I wanted it to just be focused one, one
- 21:36thing, because once we get this taken care of, then I'll go eat
- 21:40bonbons at the beach. You know, I, I just do anything
- 21:43else because I just feel like that if you focus on one point
- 21:49and this is the critical point, it seems that this is the
- 21:52critical point for us. Yes, yeah, I yeah, Martha
- 21:56absolutely right to say I mean, certainly cancer is not more and
- 22:01more realized that's exactly. So it's consider it's very
- 22:04complicated, right. All the mechanism have become
- 22:08very much clear now, but when you going to it and there are a
- 22:12lot of complication coming in and so so that's for a small
- 22:18foundation to address all the issues has become.
- 22:21I I really like as I mentioned that the early diagnosis is
- 22:26always a great and then but in this country, especially right
- 22:30from Grant, they always have the problem that you hugging to do
- 22:35it and there are a lot of people proposal, but you cannot just
- 22:39grab someone on the street to do the diagnosis.
- 22:41And then there's a lot of regulation or these and a
- 22:44tremendous difficult and so so by the same time, we do realize
- 22:49that it is important how we change that.
- 22:52And this is the the one way to change that is mega diagnosis is
- 22:56tremendously affordable and and non invasive, which means
- 23:00convenient. So we EV wise.
- 23:03So we, we working on it first to prove that indeed by looking at
- 23:08the extra vesicles. So you are looking at some of
- 23:10these protein really, really relevant to the disease number
- 23:14one. And second one is that no, we
- 23:16actually working on a format. We make him as submit a
- 23:19manuscript. We acknowledge your foundation
- 23:22is that we are working on we can basically collect the blood just
- 23:26like a dry blood spot and we can develop a device essentially you
- 23:31you deposit a blood Capri blood on the device by yourself.
- 23:37And then so we have a material to collect the EVs and we
- 23:42demonstrated these EVs still intact.
- 23:45Even if you after that they put into super back emailed into
- 23:48like a clear level or something, the EV is still stable and so
- 23:52that you can really click that at home.
- 23:55And hopefully that would really allow patients or these high
- 23:59risk populations with the family history of cancer so that they
- 24:05can essentially collect the samples at home instead of we
- 24:08need to go into clinic and then send it to clear labs and the so
- 24:14you can get the data immediately online or something that then
- 24:18that's the direction my lab is going to is hopefully make it
- 24:22tremendously convenient, affordable.
- 24:25Well, OK, I'll give you about a week and so to do that, OK,
- 24:28just. Take, take.
- 24:30Weeks off and then have fix it OK.
- 24:32We definitely will work on it, Samantha.
- 24:35Well. Thank you.
- 24:35Is there anything else that you would like to address or that
- 24:39you would like for our audience to be aware of?
- 24:41Well, so I, I certainly, I would say tremendously appreciative to
- 24:48we pretty also have some of the small foundations connections
- 24:53through our Cancer Center put we have also NEC identity Cancer
- 24:57Center. We ought to reach look
- 24:59foundation all these and then so also national foundation such as
- 25:03your foundation as a university faculty member, researchers.
- 25:08We tremendously these days being affected by the policies in in
- 25:14the government. They, I mean, usually consider
- 25:18very stable, but these days become incredible unstable and
- 25:23and the foundation like you, I think really may make a
- 25:26difference in many cases as we really appreciate that we still
- 25:30have alternative way to finding our research, ongoing research.
- 25:34Instead, we need to shut it, shut it down.
- 25:36And so that's the part we really appreciate that especially I
- 25:40knew a lot of foundation money, you guys just get the money from
- 25:44the people who do net really from their pocket just like like
- 25:48that. So we fully understand that.
- 25:50We try to use the money really on critical research.
- 25:54We usually, I came from the chemistry major, which is doing
- 25:58really fundamental research. You don't have interaction with
- 26:01patient or these things. And then when I become faculty
- 26:05member and I'm really working on something, I feel like it could
- 26:09make a difference. I really tried to tell my
- 26:12students saying that you're doing research, are you willing
- 26:15to put in your money to do the research?
- 26:17Some students say, well, probably no.
- 26:19But I said to them, well, the money you're getting support
- 26:22actually from someone's pocket. OK.
- 26:25It is from someone's pocket like that.
- 26:27Yeah. So I I must really appreciate
- 26:30the support. Well, thank you.
- 26:32I know our donors really appreciate what your work is and
- 26:37what everyone's doing. And they have been very, very
- 26:40generous and very supportive. And it used to be when I started
- 26:45out and there was a question mark over their head, but now
- 26:48they just put a bag over their head because they don't want to
- 26:51see me asking them for money anymore.
- 26:53But I'll keep doing it. So that's what we do.
- 26:56We keep trying to raise funds for you.
- 26:58Also. Thank you for your work and stay
- 27:01in touch with us and keep us updated.
- 27:03I'll be very interested in that. And also to let you know that
- 27:06the grant proposal deadline was extended to February 15th if if
- 27:12you're looking to submit. So it's still an opportunity for
- 27:17you. Wonderful, Samantha, that's
- 27:20good. And maybe next year I feel that
- 27:21I get funded. I, I feel that you guys want to
- 27:23fund the funded the different researchers.
- 27:26I haven't give a thought. Maybe maybe next year or
- 27:29something like that. I, I will, as I mentioned,
- 27:31that's the, the dried blood spot based the EV's.
- 27:34I feel that's a tremendous way. I, I, I feel very promising and
- 27:38a direction I feel excited about it to probably fit with the
- 27:41overall division of your foundation.
- 27:44I would definitely put together maybe for next year.
- 27:47Well, thank you so much. Thank you for your time.
- 27:49It's very nice to meet you and good luck and stay in touch with
- 27:53us. Thank you.
- 27:54Great talking to you about that. Episode of Isn't That
- 27:58Interesting was made possible thanks to volunteers and donors
- 28:01just like you. It was hosted by Martha Kaley,
- 28:04founderofearlier.org and edited by Liam Mcburney.
- 28:08I'm Valerie Amsterdam. Reminding you that for the last
- 28:1130 years, this is North Carolina based organization has helped
- 28:15fund groundbreaking research all over the world, from molecular
- 28:19imaging to a sensitive blood test for breast cancer.
- 28:23Plain and simple, earlier detection saves lives and you
- 28:26can help host a fundraising event.
- 28:28Make a donation for Volunteer your time.
- 28:31You can find us not only on the web but on Facebook and
- 28:34Instagram too. Let's change the picture of
- 28:36breast cancer together.